Skip to content
value.today

Embecta Corp. vs Emergent BioSolutions Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Embecta Corp. and Emergent BioSolutions Inc. are worth about the same: $366 M and $365 M (market caps of Oct 29, 2026).
  • Embecta Corp. had more revenue: $1.1 B in the year to September 2025 against $743 M for Emergent BioSolutions Inc. in the year to December 2025.
  • Embecta Corp. earned more: net income of $95 M against $53 M for Emergent BioSolutions Inc.
  • Embecta Corp. keeps more of each dollar of sales: a net margin of 8.8% against 7.1% for Emergent BioSolutions Inc.
  • Emergent BioSolutions Inc. employs more people: 2,416 against 1,850 at Embecta Corp. Each employee brings in about $584,000 of revenue at Embecta Corp. and $307,492 at Emergent BioSolutions Inc.
  • Embecta Corp.'s revenue grew faster in its latest fiscal year: -3.8% against -28.8% for Emergent BioSolutions Inc.
  • On the Piotroski F-score, a nine-point test of improving finances, Embecta Corp. scores 6 and Emergent BioSolutions Inc. 8. Both are in the distress zone of the Altman Z-score.

Market value, the same start = 100

From Dec 2022: how each one's value moved, whatever its size.

02550751002023202420252026Embecta Corp. 23Emergent BioSolutions Inc. 66

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$1B$1B$2B201720182019202020212022202320242025Embecta Corp. $1BEmergent BioSolutions Inc. $1B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureEmbecta Corp.
EMBC · #13,886 in the world
Emergent BioSolutions Inc.
EBS · #13,903 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
Industry—Pharmaceutical
Founded—1998
Size
Market cap$366 M$365 M
Revenue$1.1 B$743 M
Net income$95 M▲ best$53 M
Employees1,8502,416
Valuation
P/E ratio4.2×—
Price to sales0.4×0.6×
Price to book—0.7×
Free cash flow yield49.8%▲ best43.0%
Profitability
Gross margin62.6%▲ best56.1%
Operating margin22.4%▲ best13.5%
Net margin8.8%▲ best7.1%
Return on equity—10.5%
Return on invested capital31.1%▲ best6.4%
Growth
Revenue growth-3.8%▲ best-28.8%
Revenue growth, 3 years a year-1.5%▲ best-12.7%
Earnings per share growth20.9%—
Financial strength
Debt to equity—1.1×
Net debt to EBITDA4.2×2.0×▲ best
Cash
Free cash flow margin16.9%21.1%▲ best
Shareholder returns
Dividend yield9.6%—
Shareholder yield9.6%▲ best6.8%
Strength scores
Piotroski F-score6 of 98 of 9▲ best
Altman Z-score zonedistressdistress
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Oct 2026; ratios FY2025

Questions and answers#

Which is bigger, Embecta Corp. or Emergent BioSolutions Inc.?

Embecta Corp. and Emergent BioSolutions Inc. are worth about the same: $366 M and $365 M (market caps of Oct 29, 2026).

Which makes more money, Embecta Corp. or Emergent BioSolutions Inc.?

Embecta Corp. had more revenue: $1.1 B in the year to September 2025 against $743 M for Emergent BioSolutions Inc. in the year to December 2025. Embecta Corp. earned more: net income of $95 M against $53 M for Emergent BioSolutions Inc.

Which is more profitable, Embecta Corp. or Emergent BioSolutions Inc.?

Embecta Corp. keeps more of each dollar of sales: a net margin of 8.8% against 7.1% for Emergent BioSolutions Inc.

Which has more employees, Embecta Corp. or Emergent BioSolutions Inc.?

Emergent BioSolutions Inc. employs more people: 2,416 against 1,850 at Embecta Corp. Each employee brings in about $584,000 of revenue at Embecta Corp. and $307,492 at Emergent BioSolutions Inc.

Which is growing faster, Embecta Corp. or Emergent BioSolutions Inc.?

Embecta Corp.'s revenue grew faster in its latest fiscal year: -3.8% against -28.8% for Emergent BioSolutions Inc.

Which is financially stronger, Embecta Corp. or Emergent BioSolutions Inc.?

On the Piotroski F-score, a nine-point test of improving finances, Embecta Corp. scores 6 and Emergent BioSolutions Inc. 8. Both are in the distress zone of the Altman Z-score.